Home | Products | News | Contact Us
   

Nutraceutical News

Australia rethinks nutrient labelling and health claims standards
EFSA approves new vitamins and minerals for foods and supplements
Children positive on organic, free-range and hormone-free
Calcium sales growth suffering from lack of novelty
West follow East's functional lead?
Women Looking For An Alternative To Black Cohosh






 

Resveratrol Clinical Study


Synthesis and Cytotoxic Evaluation of a Series of Resveratrol Derivatives.

Ruan BF, Huang XF, Ding H, Xu C, Ge HM, Zhu HL, Tan RX.

Institute of Functional Biomolecules, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, P. R. China (phone: +86-25-8359 2085; fax: +86-25-8330 2728).

A total of 17 resveratrol (=(E)-5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol) derivatives were synthesized from resveratrol (RES) through a facile approach. Among them, 13 compounds, 2 and 6-17, were reported for the first time, while 1 and 3-5 had already been reported several years ago. The cytotoxic activities of these compounds were evaluated against human nasopharyngeal epidermoid tumor cell line KB, and compounds 1 and 8-11 showed strong anticancer activities in vitro, comparable with that of 5-fluorouracil, an anticancer drug. On the basis of the experimental data obtained, structure-activity relationships are discussed.

PMID: 17193329 [PubMed - as supplied by publisher]


<< Back to All Natural Products List

© Copyright 2007 - Nutraceutical Ingredients - All Rights Reservec